Literature DB >> 29157618

Pathology of Castleman Disease.

David Wu1, Megan S Lim2, Elaine S Jaffe3.   

Abstract

The term Castleman disease encompasses several distinct lymphoproliferative disorders with different underlying disease pathogenesis, and clinical outcomes. It includes unicentric and multicentric diseases with limited versus significant systemic symptoms, respectively. Importantly, the histopathologic features encountered in the various forms of Castleman disease are diverse, and for the most part, lack specificity, because they are seen to varying degrees in different clinical variants of Castleman disease, and in reactive (autoimmune/infectious) and malignant (lymphoma) contexts. Accordingly, accurate clinical diagnosis of Castleman disease requires careful and thorough clinicopathologic correlation. An overview of the key histopathologic features of Castleman disease is presented.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Castleman disease; HHV8/KSHV; Hyaline-vascular; Hypervascular; Pathology; Plasmacytic features; TAFRO

Mesh:

Year:  2018        PMID: 29157618     DOI: 10.1016/j.hoc.2017.09.004

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  18 in total

1.  Histologic and Laboratory Characteristics of Symptomatic and Asymptomatic Castleman Disease in the Pediatric Population.

Authors:  Karen M Chisholm; Mark D Fleming
Journal:  Am J Clin Pathol       Date:  2020-05-05       Impact factor: 2.493

Review 2.  Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review.

Authors:  Małgorzata Wojtyś; Agnieszka Piekarska; Michał Kunc; Konrad Ptaszyński; Wojciech Biernat; Jan Maciej Zaucha; Piotr Waloszczyk; Piotr Lisowski; Bartosz Kubisa; Tomasz Grodzki
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

Review 3.  KSHV/HHV8-mediated hematologic diseases.

Authors:  Ethel Cesarman; Amy Chadburn; Paul G Rubinstein
Journal:  Blood       Date:  2022-02-17       Impact factor: 22.113

4.  [Progress in the diagnosis and treatment of Castleman disease].

Authors:  H L Liu; L Fan; J Y Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-08-14

Review 5.  Updates on the diagnosis and management of multicentric Castleman disease.

Authors:  Ya-Ju Wu; Kuei-Ying Su
Journal:  Tzu Chi Med J       Date:  2020-07-29

6.  Idiopathic Multicentric Hyaline Vascular-Type Castleman Disease.

Authors:  Adelaide Moutinho; Rita Gamboa Cunha; Sheila Koch Jamal; Marta Meleiro Lisboa; Sandra Tavares
Journal:  Case Rep Hematol       Date:  2021-04-15

7.  Calcified fibrous pseudotumor with Castleman disease.

Authors:  İsmail Harmankaya; Nevzat Serdar Ugras; Tamer Sekmenli; Fatih Demir; Yavuz Köksal
Journal:  Autops Case Rep       Date:  2018-07-30

8.  Castleman flare or COPD exacerbation- can biomarkers override availability bias?

Authors:  Benjamin B Claxton; Anne E F Dimmock; Rohit Jain; M Bradley Drummond; Rebecca Bascom
Journal:  Respir Med Case Rep       Date:  2020-05-22

9.  Rare retroperitoneal conditions that mimic uterine myoma.

Authors:  Răzvan Mihai Popovici; Alexandru Cărăuleanu; Claudia Florida Costea; Irina Daniela Florea; Dragoş Viorel Scripcariu; Raluca Anamaria Mogoş; Ali Cheaito; Adina Elena Tănase; Raluca Maria Haba; Mihaela Grigore
Journal:  Rom J Morphol Embryol       Date:  2020       Impact factor: 1.033

Review 10.  A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease.

Authors:  Alexandra Butzmann; Jyoti Kumar; Kaushik Sridhar; Sumanth Gollapudi; Robert S Ohgami
Journal:  Biology (Basel)       Date:  2021-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.